News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
NCI presents Leveraging Data Standards for Improving Interoperability
Photo taken from National Cancer Institute (NCI)/LinkedIn
Jun 29, 2024, 06:08

NCI presents Leveraging Data Standards for Improving Interoperability

National Cancer Institute (NCI) shared the following on LinkedIn:

“REGISTER TODAY: Join us for the next event in the Childhood Cancer Data Initiative Webinar Series on how to enhance interoperability with data standards, including the National Childhood Cancer Registry, CC-DIRECT, and more.”

Additional information.
Source: National Cancer Institute (NCI)/LinkedIn
.

cancer Cancer research CC-DIRECT Childhood Cancer Data Initiative data standards Healthcare Webinar interoperability National Cancer Institute National Childhood Cancer Registry NCI OncoDaily Oncology
Special Coverage
Blog
Apr 22, 2025, 10:11
Insights into the protective role of the BRCA2 gene - Cancer Research Institute
Blog
Apr 22, 2025, 10:03
FDA Approves Qfitlia (fitusiran) for Hemophilia A and B - The Babak Lab
Blog
Apr 22, 2025, 09:55
UF Health Cancer Center at the AACR Annual Meeting 2025
Blog
Apr 22, 2025, 09:49
Building a world-class grants program is easier said than done—but it’s also more critical than ever - ASCO
Blog
Apr 22, 2025, 09:40
Devika Das: The HER2 diagnostic and treatment landscape in NSCLC
Blog
Apr 22, 2025, 09:32
Nwamaka Lasebikan: Redefining Research Leadership in Africa with SINCCAR
Blog
Apr 22, 2025, 09:19
Wafik S. El-Deiry: Our enemy is cancer that affects all of us in some way
Science
Apr 22, 2025, 09:14
Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski
Oncolibrary
Apr 22, 2025, 09:05
Why Does Chemotherapy Cause Hair Loss?
Blog
Apr 22, 2025, 09:03
Key sessions you can’t miss at ESTRO25
Blog
Apr 22, 2025, 09:03
High-level results from the DESTINY-Breast09 Phase III trial for patients living with HER2+ mBC - AstraZeneca
Blog
Apr 22, 2025, 08:41
Sumanta K. Pal: Hoping to see you all in this Peer View forum to discuss all the latest developments in kidney cancer therapy